Venoarterial extracorporeal membrane oxygenation in acute myocardial infarction

Conflict of interest statement

The author declares no conflict of interest.

Author contributions

Xing J wrote the article.

Funding

None.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

References

[1] Esposito M, Bader Y, Pedicini R, Breton C, Mullin A, Kapur NK. The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock. Indian Heart J. 2017; 69(5):668-674. doi:10.1016/j.ihj.2017.05.011

[2] Vallabhajosyula S, Prasad A, Bell MR, et al. Extracorporeal membrane oxygenation use in acute myocardial infarction in the United States, 2000 to 2014. Circ Heart Fail. 2019; 12(12):e005929. doi:10.1161/CIRCHEARTFAILURE.119.005929

[3] Freund A, Desch S, Pöss J, et al. Extracorporeal membrane oxygenation in infarct-related cardiogenic shock. J Clin Med. 2022; 11(5):1256. doi:10.3390/jcm11051256

[4] Al-Atta A, Zaidan M, Abdalwahab A, et al. Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. Rev Cardiovasc Med. 2022; 23(2):71. doi:10.31083/j.rcm2302071

[5] Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2):119-177. doi:10.1093/eurheartj/ehx393

[6] Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020; 396(10245):199-212. doi:10.1016/S0140-6736(20)31047-3

[7] Batchelor RJ, Wheelahan A, Zheng WC, Stub D, Yang Y, Chan W. Impella versus venoarterial extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock: a systematic review and meta-analysis. J Clin Med. 2022; 11(14):3955. doi:10.3390/jcm11143955

[8] Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016; 42(12):1922-1934. doi:10.1007/s00134-016-4536-8

[9] Zavalichi MA, Nistor I, Nedelcu AE, et al. Extracorporeal membrane oxygenation in cardiogenic shock due to acute myocardial infarction: a systematic review. Biomed Res Int. 2020; 2020:6126534. doi:10.1155/2020/6126534

[10] Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association Guidelines Update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015; 132(18Suppl 2): S444-S464. doi:10.1161/CIR.0000000000000261

[11] Hutin A, Abu-Habsa M, Burns B, et al. Early ECPR for out-of-hospital cardiac arrest: best practice in 2018. Resuscitation. 2018; 130:44-48. doi:10.1016/j.resuscitation.2018.05.004

[12] Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009; 301(17):1779-1789. doi:10.1001/jama.2009.600

[13] Tsai FC, Wang YC, Huang YK, et al. Extracorporeal life support to terminate refractory ventricular tachycardia. Crit Care Med. 2007; 35(7):1673-1676. doi:10.1097/01.CCM.0000269030.57298.AF

[14] Yeh CF, Wang CH, Tsai PR, Wu CK, Lin YH, Chen YS. Use of extracorporeal membrane oxygenation to rescue patients with refractory ventricular arrhythmia in acute myocardial infarction. Medicine (Baltimore). 2015; 94(30):e1241. doi:10.1097/MD.0000000000001241

[15] Coyan G, Anand N, Imran M, et al. ECMO and impella support strategies as a bridge to surgical repair of post-infarction ventricular septal rupture. Medicina (Kaunas). 2022; 58(5):611. doi:10.3390/medicina58050611

[16] Chung SY, Tong MS, Sheu JJ, et al. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention. Int J Cardiol. 2016; 223:412-417. doi:10.1016/j.ijcard.2016.08.068

[17] Huang CC, Hsu JC, Wu YW, et al. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock. Int J Cardiol. 2018; 269:45-50. doi:10.1016/j.ijcard.2018.07.023

[18] Nishi T, Ishii M, Tsujita K, et al. Outcomes of venoarterial extracorporeal membrane oxygenation plus intra-aortic balloon pumping for treatment of acute myocardial infarction complicated by cardiogenic shock. J Am Heart Assoc. 2022; 11(7):e023713. doi:10.1161/JAHA.121.023713

[19] Lee HH, Kim HC, Ahn CM, et al. Association between timing of extracorporeal membrane oxygenation and clinical outcomes in refractory cardiogenic shock. JACC Cardiovasc Interv. 2021; 14(10):1109-1119. doi:10.1016/j.jcin.2021.03.048

[20] Choi KH, Yang JH, Hong D, et al. Optimal timing of venoarterial-extracorporeal membrane oxygenation in acute myocardial infarction patients suffering from refractory cardiogenic shock. Circ J. 2020; 84(9):1502-1510. doi:10.1253/circj.CJ-20-0259